Recombinant Poliovirus Receptor anticorps

N° du produit ABIN7072567

Détail du produit anti-Poliovirus Receptor anticorps

Antigène: Poliovirus Receptor (PVR)

Type d'anticorp: Recombinant Antibody

Reactivité: Souris

Hôte: Lapin

Clonalité: Chimeric

Conjugué: Cet anticorp Poliovirus Receptor est non-conjugé

Application: ELISA, Flow Cytometry (FACS)

Attributs du produit:

Original Species of Ab: Rat

Original Format of Ab: IgG2a

Purification: Purified antibody.

Immunogène: This antibody was raised by immunising rats with recombinant murine CD155, consisting of the entire ectodomain expressed as a HIS-tagged protein.

Clone: 3F1

Isotype: IgG kappa

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Commentaires:

This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques.

Restrictions: For Research Use only

Stockage

Buffer: PBS with 0.02 % Proclin 300.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Détails sur Poliovirus Receptor

Antigène: Poliovirus Receptor (PVR)

Autre désignation: CD155 (PVR Produits)

Synonymes: anticorps PVR, anticorps CD155, anticorps HVED, anticorps NECL5, anticorps Necl-5, anticorps PVS, anticorps TAGE4, anticorps 3830421F03Rik, anticorps D7Ertd458e, anticorps Taa1, anticorps Tage4, anticorps mE4, anticorps necl-5, anticorps poliovirus receptor, anticorps PVR, anticorps Pvr

Sujet: TAGE 3F1, Poliovirus receptor, cellular receptor for poliovirus, Pvr, Tumor-associated antigen 1, Taa1, Tage4, HVED

UniProt: Q8K094

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Cancer Immune Checkpoints, SARS-CoV-2 Protein Interactome